Actavis Logo (Actavislogo)
Not available.*
Ondansetron
Product Images NDC 45963-539
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 45963-539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Ondanfig1)
Ondansetron Container Label (Ondansetron4mglabel)
This is a description of Ondansetron Tablets, USP with NDC 45963-538-30. Each tablet contains 5mg of Ondansetron hydrochloride dihydrate equivalent to 4mg SIS S0l ondansetron. It is manufactured in Kothur-509228, India and is recommended to be stored at 20° to 25°C (68° to 77°F). The product should be dispensed in a tight, light-resistant container as defined in the USP. This information is printed on a label with revisions made in April 2017.*
Ondansetron Container Label (Ondansetron8mglabel)
This is a medication in tablet form, Ondansetron, used for preventing nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Each tablet contains 10mg of ondansetron dihydrate equivalent to 8mg of ondansetron. The recommended dosage is not specified in the text. It should be stored at a temperature between 20 to 25 degrees Celsius. The manufacturer is located in Kothur-509 228, India, and the product is distributed in the USA by Actavis Pharma, Inc. The product comes in a tightly sealed container to protect from light as defined in the USP. Manufacturing and expiration dates are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
